Datasets:
SKT27182
/
NER_processed_data

Dataset card Data Studio Files
xet
 Community
1
id
stringlengths
11
11
tags
stringlengths
10
777
text
stringlengths
2
1.5k
dataset_num
int64
1
3
tokens
list
ner_tags
list
NCT01422746
24:56:chronic_disease
Significant history of cardiac or pulmonary dysfunction
2
[ "Significant", "history", "of", "cardiac", "or", "pulmonary", "dysfunction" ]
[ 0, 0, 0, 2, 2, 2, 2 ]
NCT00285935
4:12:treatment,
No vaccines for at least 4 weeks prior to baseline blood draw (including the flu shot)
2
[ "No", "vaccines", "for", "at", "least", "4", "weeks", "prior", "to", "baseline", "blood", "draw", "(", "including", "the", "flu", "shot", ")" ]
[ 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02536794
7:40:chronic_disease
Known active or chronic viral hepatitis
2
[ "Known", "active", "or", "chronic", "viral", "hepatitis" ]
[ 0, 2, 2, 2, 2, 2 ]
NCT02353819
1:15:cancer
Adenocarcinoma of the prostate
2
[ "Adenocarcinoma", "of", "the", "prostate" ]
[ 3, 0, 0, 0 ]
NCT03170375
1:31:chronic_disease
severely uncontrolled diabetes
2
[ "severely", "uncontrolled", "diabetes" ]
[ 2, 2, 2 ]
NCT02401035
8:13:treatment,15:25:treatment,27:38:treatment,43:60:treatment,66:86:treatment,,118:141:treatment
Use of H2RAs, sucralfate, misoprostol, or prokinetic agents, and bismuth preparations within 1 day (24 hours) before investigational product dosing on Day 1
2
[ "Use", "of", "H2RAs", ",", "sucralfate", ",", "misoprostol", ",", "or", "prokinetic", "agents", ",", "and", "bismuth", "preparations", "within", "1", "day", "(", "24", "hours", ")", "before", "investigational", "product", "dosing", "on", "Day", "1" ]
[ 0, 0, 1, 0, 1, 0, 1, 0, 0, 1, 1, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0 ]
NCT01872975
1:3:cancer,7:17:cancer,44:51:treatment
N2 or N3 disease detected clinically or by imaging
2
[ "N2", "or", "N3", "disease", "detected", "clinically", "or", "by", "imaging" ]
[ 3, 0, 3, 3, 0, 0, 0, 0, 1 ]
NCT02498613
46:62:treatment,,,119:136:treatment,140:171:treatment,180:188:treatment
The lesions have improved or remained stable radiographically and clinically for at least 6 weeks after completion of brain irradiation or stereotactic brain radiosurgery and off steroids for at least 6 weeks
2
[ "The", "lesions", "have", "improved", "or", "remained", "stable", "radiographically", "and", "clinically", "for", "at", "least", "6", "weeks", "after", "completion", "of", "brain", "irradiation", "or", "stereotactic", "brain", "radiosurgery", "and", "off", "steroi...
[ 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 1, 1, 1, 0, 0, 1, 0, 0, 0, 0, 0 ]
NCT02048371
39:51:treatment,44:51:treatment,,,,138:162:treatment,
Patients who have received wide field radiotherapy ≤ 28 days (defined as > 50% of volume of pelvis bones or equivalent) or limited field radiation for palliation < 14 days prior to study registration or those patients who have not recovered adequately from side effects of such therapy
2
[ "Patients", "who", "have", "received", "wide", "field", "radiotherapy", "≤", "28", "days", "(", "defined", "as", ">", "50", "%", "of", "volume", "of", "pelvis", "bones", "or", "equivalent", ")", "or", "limited", "field", "radiation", "for", "palliation", "...
[ 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02314377
36:52:chronic_disease,60:75:chronic_disease,77:94:chronic_disease
Patients must not have significant vascular disease (e.g., aortic aneurysm, aortic dissection)
2
[ "Patients", "must", "not", "have", "significant", "vascular", "disease", "(", "e.g.", ",", "aortic", "aneurysm", ",", "aortic", "dissection", ")" ]
[ 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 2, 2, 0, 0, 0, 0 ]
NCT02680574
1:51:treatment
surgical or percutaneous intervention for coronary
2
[ "surgical", "or", "percutaneous", "intervention", "for", "coronary" ]
[ 1, 1, 1, 1, 1, 1 ]
NCT02751866
,13:28:chronic_disease
age-related memory disorder
2
[ "age-related", "memory", "disorder" ]
[ 0, 2, 2 ]
NCT01433315
41:68:treatment
those taking any medications other than non-sedating antihistamines or oral contraceptives
2
[ "those", "taking", "any", "medications", "other", "than", "non-sedating", "antihistamines", "or", "oral", "contraceptives" ]
[ 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0 ]
NCT02531880
12:22:allergy_name
Allergy to gadolinium
2
[ "Allergy", "to", "gadolinium" ]
[ 0, 0, 4 ]
NCT01730937
1:19:treatment,24:27:cancer,43:49:cancer
prior chemotherapy for HCC or a different cancer
2
[ "prior", "chemotherapy", "for", "HCC", "or", "a", "different", "cancer" ]
[ 1, 1, 0, 3, 0, 0, 0, 3 ]
NCT02389309
59:66:chronic_disease,,
Adequate pulmonary function as defined as: no evidence of dyspnea at rest, no exercise intolerance, and a pulse oximetry > 94% if there is clinical indication for determination
2
[ "Adequate", "pulmonary", "function", "as", "defined", "as", ":", "no", "evidence", "of", "dyspnea", "at", "rest", ",", "no", "exercise", "intolerance", ",", "and", "a", "pulse", "oximetry", ">", "94", "%", "if", "there", "is", "clinical", "indication", "fo...
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02496663
4:13:treatment,49:57:treatment,,65:76:treatment,78:88:treatment,90:97:treatment,190:199:treatment,201:210:treatment,212:220:treatment,
be treatment naïve to 3rd generation and beyond EGFR-TKI (i.e., osimertinib, poziotinib, TAK-778) and EGFR monoclonal antibody; patient who received 1st or 2nd generation EGFR-TKI (such as erlotinib, gefitinib, afatinib) are eligible provided that they did not achieve a response to treatment or they did not have a dura...
2
[ "be", "treatment", "naïve", "to", "3rd", "generation", "and", "beyond", "EGFR-TKI", "(", "i.e.", ",", "osimertinib", ",", "poziotinib", ",", "TAK-778", ")", "and", "EGFR", "monoclonal", "antibody", ";", "patient", "who", "received", "1st", "or", "2nd", "gene...
[ 0, 1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 1, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0...
NCT01280669
17:31:chronic_disease
Any significant ocular disease that could compromise the visual outcome in the study eye
2
[ "Any", "significant", "ocular", "disease", "that", "could", "compromise", "the", "visual", "outcome", "in", "the", "study", "eye" ]
[ 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02421276
16:71:chronic_disease,,,
Diagnosed with idiopathic or secondary pulmonary arterial hypertension as defined by a mean pulmonary artery pressure > 25 mmHg at rest or > 30 mmHg with exercise
2
[ "Diagnosed", "with", "idiopathic", "or", "secondary", "pulmonary", "arterial", "hypertension", "as", "defined", "by", "a", "mean", "pulmonary", "artery", "pressure", ">", "25", "mmHg", "at", "rest", "or", ">", "30", "mmHg", "with", "exercise" ]
[ 0, 0, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01953588
30:50:cancer,
Mammogram for the unaffected contralateral breast is required within 12 months prior to registration
2
[ "Mammogram", "for", "the", "unaffected", "contralateral", "breast", "is", "required", "within", "12", "months", "prior", "to", "registration" ]
[ 0, 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03005418
56:76:treatment
Known medical condition which would preclude long term antiplatelet therapy after resolution of acute injuries
2
[ "Known", "medical", "condition", "which", "would", "preclude", "long", "term", "antiplatelet", "therapy", "after", "resolution", "of", "acute", "injuries" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0 ]
NCT02931110
1:29:chronic_disease
extranodal organ involvement
2
[ "extranodal", "organ", "involvement" ]
[ 2, 2, 2 ]
NCT01591356
17:44:treatment
continuation of hormone replacement therapy is permitted
2
[ "continuation", "of", "hormone", "replacement", "therapy", "is", "permitted" ]
[ 0, 0, 1, 1, 1, 0, 0 ]
NCT02932280
1:13:cancer
Solid tumors must have a lesion evaluable by RECIST criteria version 1.1
2
[ "Solid", "tumors", "must", "have", "a", "lesion", "evaluable", "by", "RECIST", "criteria", "version", "1.1" ]
[ 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02016781
27:34:treatment
No intent to proceed with alloHCT using donor sources not specified in this protocol, including human leukocyte antigen (HLA)-mismatched related or unrelated donors
2
[ "No", "intent", "to", "proceed", "with", "alloHCT", "using", "donor", "sources", "not", "specified", "in", "this", "protocol", ",", "including", "human", "leukocyte", "antigen", "(", "HLA", ")", "-mismatched", "related", "or", "unrelated", "donors" ]
[ 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02901041
1:14:chronic_disease
schizophrenia
2
[ "schizophrenia" ]
[ 2 ]
NCT02476409
29:48:chronic_disease
Planned hospitalization for acute heart failure
2
[ "Planned", "hospitalization", "for", "acute", "heart", "failure" ]
[ 0, 0, 0, 2, 2, 2 ]
NCT02494258
10:26:treatment
received oral azacitidine
2
[ "received", "oral", "azacitidine" ]
[ 0, 1, 1 ]
NCT03163901
14:53:chronic_disease
Diagnosis of mild to moderate traumatic brain injury
2
[ "Diagnosis", "of", "mild", "to", "moderate", "traumatic", "brain", "injury" ]
[ 0, 0, 2, 2, 2, 2, 2, 2 ]
NCT02129348
70:73:treatment
unstable cardiac disease based on history, physical examination, and ECG
2
[ "unstable", "cardiac", "disease", "based", "on", "history", ",", "physical", "examination", ",", "and", "ECG" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02654236
34:45:chronic_disease,47:58:chronic_disease,63:66:chronic_disease
Known co-existing infection with hepatitis C, hepatitis B, or HIV
2
[ "Known", "co-existing", "infection", "with", "hepatitis", "C", ",", "hepatitis", "B", ",", "or", "HIV" ]
[ 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 2 ]
NCT02487082
1:24:chronic_disease
Cardiovascular problems
2
[ "Cardiovascular", "problems" ]
[ 2, 2 ]
NCT03112863
29:37:treatment,41:59:treatment,,123:140:chronic_disease,150:176:treatment,178:192:treatment,194:215:treatment,232:251:treatment
Those who have had a recent surgical or cosmetic procedure in the last 3 months that can affect facial wrinkles or facial hyperpigmentation, such as botulinum toxin injections, chemical peels, laser based therapies to the face, or face lift surgeries
2
[ "Those", "who", "have", "had", "a", "recent", "surgical", "or", "cosmetic", "procedure", "in", "the", "last", "3", "months", "that", "can", "affect", "facial", "wrinkles", "or", "facial", "hyperpigmentation", ",", "such", "as", "botulinum", "toxin", "injection...
[ 0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 1, 1, 1, 0, 1, 1, 0, 1, 1, 1, 0, 0, 1, 1, 1, 0, 0, 0 ]
NCT02508311
74:85:treatment
Use or are suspected of using over-the counter supplements or prescribed medications with anabolic characteristics (promotes improvements to muscle mass and strength)
2
[ "Use", "or", "are", "suspected", "of", "using", "over-the", "counter", "supplements", "or", "prescribed", "medications", "with", "anabolic", "characteristics", "(", "promotes", "improvements", "to", "muscle", "mass", "and", "strength", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02335905
1:17:chronic_disease,
Thrombocytopenia (less than 50,000 platelets/mm^3)
2
[ "Thrombocytopenia", "(", "less", "than", "50,000", "platelets/mm^3", ")" ]
[ 2, 0, 0, 0, 0, 0, 0 ]
NCT03006913
32:38:cancer
don't have a family history of cancer
2
[ "do", "n't", "have", "a", "family", "history", "of", "cancer" ]
[ 0, 0, 0, 0, 0, 0, 0, 3 ]
NCT02437110
10:29:chronic_disease,41:50:chronic_disease,64:80:chronic_disease,
Unstable psychiatric illness defined as psychosis or untreated major depression within 90 days of the screening visit
2
[ "Unstable", "psychiatric", "illness", "defined", "as", "psychosis", "or", "untreated", "major", "depression", "within", "90", "days", "of", "the", "screening", "visit" ]
[ 0, 2, 2, 0, 0, 2, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT02164734
18:21:chronic_disease
Mild-to-moderate RDS
2
[ "Mild-to-moderate", "RDS" ]
[ 0, 2 ]
NCT02473250
1:14:chronic_disease
hypersplenism
2
[ "hypersplenism" ]
[ 2 ]
NCT02035137
24:42:treatment
They have had previous I-131 MIBG therapy
2
[ "They", "have", "had", "previous", "I-131", "MIBG", "therapy" ]
[ 0, 0, 0, 0, 1, 1, 1 ]
NCT00412594
13:27:cancer
Presence of CNS metastases
2
[ "Presence", "of", "CNS", "metastases" ]
[ 0, 0, 3, 3 ]
NCT02177695
20:59:cancer,53:59:cancer,61:84:cancer,105:125:cancer,
adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, adequately treated Stage I or II cancer from which the patient is currently in complete remission, or any other cancer from which the patient has been disease free for five years
2
[ "adequately", "treated", "basal", "cell", "or", "squamous", "cell", "skin", "cancer", ",", "in", "situ", "cervical", "cancer", ",", "adequately", "treated", "Stage", "I", "or", "II", "cancer", "from", "which", "the", "patient", "is", "currently", "in", "comp...
[ 0, 0, 3, 3, 3, 3, 3, 3, 3, 0, 3, 3, 3, 3, 0, 0, 0, 3, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01625923
12:28:chronic_disease
History of seizure disorder
2
[ "History", "of", "seizure", "disorder" ]
[ 0, 0, 2, 2 ]
NCT03110107
19:43:cancer,48:54:cancer,60:74:cancer
Participants with primary CNS malignancies, or tumors with CNS metastases as the only site of disease, will be excluded
2
[ "Participants", "with", "primary", "CNS", "malignancies", ",", "or", "tumors", "with", "CNS", "metastases", "as", "the", "only", "site", "of", "disease", ",", "will", "be", "excluded" ]
[ 0, 0, 3, 3, 3, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02857218
1:37:chronic_disease
symptomatic congestive heart failure
2
[ "symptomatic", "congestive", "heart", "failure" ]
[ 2, 2, 2, 2 ]
NCT02947165
15:38:treatment,,129:162:treatment,203:215:treatment
Resistance to anti-PD-1/PD-L1 therapy is defined as: Documented progressive disease occurring while on/or within 6 months after anti-PD-1 and/or anti-PD-L1 agent (single or combination) received as the last therapy prior to enrollment
2
[ "Resistance", "to", "anti-PD-1/PD-L1", "therapy", "is", "defined", "as", ":", "Documented", "progressive", "disease", "occurring", "while", "on/or", "within", "6", "months", "after", "anti-PD-1", "and/or", "anti-PD-L1", "agent", "(", "single", "or", "combination", ...
[ 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0 ]
NCT01983475
1:37:treatment,
Anabolic or Steroid hormonal therapy; within the past year and longer than six months
2
[ "Anabolic", "or", "Steroid", "hormonal", "therapy", ";", "within", "the", "past", "year", "and", "longer", "than", "six", "months" ]
[ 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03089515
1:25:chronic_disease
bladder-neck obstruction
2
[ "bladder-neck", "obstruction" ]
[ 2, 2 ]
NCT02474368
25:43:cancer
Cohort 2 (patients with metastatic disease with targetable lesions within the head and neck)
2
[ "Cohort", "2", "(", "patients", "with", "metastatic", "disease", "with", "targetable", "lesions", "within", "the", "head", "and", "neck", ")" ]
[ 0, 0, 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02236013
16:45:chronic_disease
Subject has an active uncontrolled infection
2
[ "Subject", "has", "an", "active", "uncontrolled", "infection" ]
[ 0, 0, 0, 2, 2, 2 ]
NCT02762032
5:28:chronic_disease
Any dermatological disorder that may interfere with the accurate evaluation of the subject's skin
2
[ "Any", "dermatological", "disorder", "that", "may", "interfere", "with", "the", "accurate", "evaluation", "of", "the", "subject", "'s", "skin" ]
[ 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02243813
23:52:treatment
Agree not to take any Pro-re-nata (PRN) medications on the mornings of drug sessions
2
[ "Agree", "not", "to", "take", "any", "Pro-re-nata", "(", "PRN", ")", "medications", "on", "the", "mornings", "of", "drug", "sessions" ]
[ 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02474173
38:60:treatment,,
Patients who are receiving any other investigational agents within 4 weeks or 5 half-lives (whichever is shorter) prior to the first dose of the study regimen
2
[ "Patients", "who", "are", "receiving", "any", "other", "investigational", "agents", "within", "4", "weeks", "or", "5", "half-lives", "(", "whichever", "is", "shorter", ")", "prior", "to", "the", "first", "dose", "of", "the", "study", "regimen" ]
[ 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01568255
1:11:cancer
Metastatic malignancy
2
[ "Metastatic", "malignancy" ]
[ 3, 0 ]
NCT02053792
36:64:treatment
Never previously been treated with FIX clotting factor products
2
[ "Never", "previously", "been", "treated", "with", "FIX", "clotting", "factor", "products" ]
[ 0, 0, 0, 0, 0, 1, 1, 1, 1 ]
NCT02898597
14:27:chronic_disease
Diagnosis of HIV infection
2
[ "Diagnosis", "of", "HIV", "infection" ]
[ 0, 0, 2, 2 ]
NCT01970345
1:22:chronic_disease
Hepatic insufficiency
2
[ "Hepatic", "insufficiency" ]
[ 2, 2 ]
NCT02398240
4:43:treatment,75:98:treatment,,114:147:cancer
No prior Hodgkin lymphoma directed therapy is allowed except for emergent mediastinal irradiation (<1000cGy) for superior vena cava (SVC) syndrome
2
[ "No", "prior", "Hodgkin", "lymphoma", "directed", "therapy", "is", "allowed", "except", "for", "emergent", "mediastinal", "irradiation", "(", "<", "1000cGy", ")", "for", "superior", "vena", "cava", "(", "SVC", ")", "syndrome" ]
[ 0, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 3, 3, 3, 3, 3, 0, 0 ]
NCT01878617
14:38:chronic_disease
Must have no congenital heart disease
2
[ "Must", "have", "no", "congenital", "heart", "disease" ]
[ 0, 0, 0, 2, 2, 2 ]
NCT02268253
11:36:treatment
receiving immunosuppressive therapy
2
[ "receiving", "immunosuppressive", "therapy" ]
[ 0, 1, 1 ]
NCT02133898
1:18:chronic_disease
Suicidal ideation
2
[ "Suicidal", "ideation" ]
[ 2, 2 ]
NCT01943851
33:44:treatment,
This includes excluding current medications known or suspected to be associated QT prolongation
2
[ "This", "includes", "excluding", "current", "medications", "known", "or", "suspected", "to", "be", "associated", "QT", "prolongation" ]
[ 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02354547
,41:70:treatment
At least 21 days after the last dose of myelosuppressive chemotherapy
2
[ "At", "least", "21", "days", "after", "the", "last", "dose", "of", "myelosuppressive", "chemotherapy" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02110992
1:37:cancer
Primary tumors of the salivary gland
2
[ "Primary", "tumors", "of", "the", "salivary", "gland" ]
[ 3, 3, 3, 3, 3, 3 ]
NCT02640950
12:23:chronic_disease,25:33:chronic_disease,37:53:chronic_disease,55:86:treatment
History of head injury, epilepsy or seizure disorder, non-removable metallic implants or objects in or around the head
2
[ "History", "of", "head", "injury", ",", "epilepsy", "or", "seizure", "disorder", ",", "non-removable", "metallic", "implants", "or", "objects", "in", "or", "around", "the", "head" ]
[ 0, 0, 2, 2, 0, 2, 0, 2, 2, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02331095
89:91:chronic_disease,141:159:treatment,161:170:treatment,188:207:treatment,209:219:treatment,221:247:treatment
A diagnosis of proximal DVT (proximal to and including popliteal vein), with or without PE, confirmed by objective imaging studies, such as Doppler ultrasound, venograms (for DVT) and/or computer tomography, angiograms, ventilation-perfusion scan (for PE)
2
[ "A", "diagnosis", "of", "proximal", "DVT", "(", "proximal", "to", "and", "including", "popliteal", "vein", ")", ",", "with", "or", "without", "PE", ",", "confirmed", "by", "objective", "imaging", "studies", ",", "such", "as", "Doppler", "ultrasound", ",", ...
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 1, 0, 0, 0, 0, 0, 1, 1, 0, 1, 0, 1, 1, 0, 0, 0, 0 ]
NCT02072148
10:25:chronic_disease,34:43:treatment,45:66:chronic_disease
Unstable cardiac disease despite treatment, myocardial infarction with months prior to study entry
2
[ "Unstable", "cardiac", "disease", "despite", "treatment", ",", "myocardial", "infarction", "with", "months", "prior", "to", "study", "entry" ]
[ 0, 2, 2, 0, 1, 0, 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT00488696
1:29:chronic_disease
Free rupture of the aneurysm
2
[ "Free", "rupture", "of", "the", "aneurysm" ]
[ 2, 2, 2, 2, 2 ]
NCT03119467
20:34:treatment,
Patients receiving cancer therapy within 3 weeks prior to Cycle1 Day1 (C1D1)
2
[ "Patients", "receiving", "cancer", "therapy", "within", "3", "weeks", "prior", "to", "Cycle1", "Day1", "(", "C1D1", ")" ]
[ 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02878044
32:46:cancer
Clinical diagnosis of low risk thyroid cancer
2
[ "Clinical", "diagnosis", "of", "low", "risk", "thyroid", "cancer" ]
[ 0, 0, 0, 0, 0, 3, 3 ]
NCT03029884
13:33:chronic_disease,,
Significant cognitive impairment or Dementia (MoCA < 25)
2
[ "Significant", "cognitive", "impairment", "or", "Dementia", "(", "MoCA", "<", "25", ")" ]
[ 0, 2, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT02031250
14:33:treatment
referred for definitive chemo‐RT
2
[ "referred", "for", "definitive", "chemo‐RT" ]
[ 0, 0, 1, 1 ]
NCT02169037
1:21:treatment,,
oral anticoagulation required for those subjects who have a score of two or more based on the following criteria (CHAD score)
2
[ "oral", "anticoagulation", "required", "for", "those", "subjects", "who", "have", "a", "score", "of", "two", "or", "more", "based", "on", "the", "following", "criteria", "(", "CHAD", "score", ")" ]
[ 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02554786
,,,,105:120:treatment
Pre-bronchodilator ≥ 50% FEV1 of < 85 % of the predicted normal value for the patient after withholding bronchodilators at both Visit 101 and 102, according to ATS/ERS criteria
2
[ "Pre-bronchodilator", "≥", "50", "%", "FEV1", "of", "<", "85", "%", "of", "the", "predicted", "normal", "value", "for", "the", "patient", "after", "withholding", "bronchodilators", "at", "both", "Visit", "101", "and", "102", ",", "according", "to", "ATS/ERS"...
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02789111
1:31:chronic_disease
Chronic kidney disease stage 5
2
[ "Chronic", "kidney", "disease", "stage", "5" ]
[ 2, 2, 2, 2, 2 ]
NCT02417701
20:36:treatment
Ability to swallow oral medications
2
[ "Ability", "to", "swallow", "oral", "medications" ]
[ 0, 0, 0, 1, 1 ]
NCT02535286
5:18:treatment,20:32:treatment,36:49:treatment,
Any major surgery, chemotherapy or immunotherapy within the last 14 days
2
[ "Any", "major", "surgery", ",", "chemotherapy", "or", "immunotherapy", "within", "the", "last", "14", "days" ]
[ 0, 1, 1, 0, 1, 0, 1, 0, 0, 0, 0, 0 ]
NCT02108860
3:19:treatment,
A live vaccination fewer than 3 months before enrollment
2
[ "A", "live", "vaccination", "fewer", "than", "3", "months", "before", "enrollment" ]
[ 0, 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT02931110
1:13:chronic_disease
organomegaly
2
[ "organomegaly" ]
[ 2 ]
NCT02557321
37:48:chronic_disease,52:65:treatment,,89:111:treatment,119:136:treatment
there is no evidence of progressive CNS disease on brain imaging at least 90 days after treatment with surgery and/or radiation therapy
2
[ "there", "is", "no", "evidence", "of", "progressive", "CNS", "disease", "on", "brain", "imaging", "at", "least", "90", "days", "after", "treatment", "with", "surgery", "and/or", "radiation", "therapy" ]
[ 0, 0, 0, 0, 0, 0, 2, 2, 0, 1, 1, 0, 0, 0, 0, 0, 1, 1, 1, 0, 1, 1 ]
NCT01989585
7:26:treatment,42:51:treatment,60:78:treatment
Other anti-cancer therapy while on study treatment; (note: megestrol [Megace] if used as an appetite stimulant is allowed)
2
[ "Other", "anti-cancer", "therapy", "while", "on", "study", "treatment", ";", "(", "note", ":", "megestrol", "[", "Megace", "]", "if", "used", "as", "an", "appetite", "stimulant", "is", "allowed", ")" ]
[ 0, 1, 1, 0, 0, 0, 1, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02033616
27:33:allergy_name
Known hypersensitivity to GM-CSF
2
[ "Known", "hypersensitivity", "to", "GM-CSF" ]
[ 0, 0, 0, 4 ]
NCT02494869
64:70:cancer
Clinical breast exam interpreted as benign (not suspicious for cancer) at MSK
2
[ "Clinical", "breast", "exam", "interpreted", "as", "benign", "(", "not", "suspicious", "for", "cancer", ")", "at", "MSK" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0 ]
NCT02169037
11:13:chronic_disease
sustained AF during the procedure
2
[ "sustained", "AF", "during", "the", "procedure" ]
[ 0, 2, 0, 0, 0 ]
NCT02615353
1:16:chronic_disease,,,,
Type 2 diabetes: Fasting glucose ≥126 mg/dl or 2-hour glucose ≥200 mg/dl
2
[ "Type", "2", "diabetes", ":", "Fasting", "glucose", "≥126", "mg/dl", "or", "2-hour", "glucose", "≥200", "mg/dl" ]
[ 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01415882
11:26:treatment,28:51:treatment,53:64:treatment,68:80:treatment,
High dose corticosteroids, immune modulatory drugs (thalidomide or lenalidomide) =< 7 days prior to registration
2
[ "High", "dose", "corticosteroids", ",", "immune", "modulatory", "drugs", "(", "thalidomide", "or", "lenalidomide", ")", "=", "<", "7", "days", "prior", "to", "registration" ]
[ 0, 0, 1, 0, 1, 1, 1, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02495168
32:43:treatment
Able to continue the following medications without a significant adjustment of dosage, formulation, dosing interval for the duration of the study
2
[ "Able", "to", "continue", "the", "following", "medications", "without", "a", "significant", "adjustment", "of", "dosage", ",", "formulation", ",", "dosing", "interval", "for", "the", "duration", "of", "the", "study" ]
[ 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02401347
5:24:treatment,
Any anti-cancer therapy within the past 21 days of the first day of treatment
2
[ "Any", "anti-cancer", "therapy", "within", "the", "past", "21", "days", "of", "the", "first", "day", "of", "treatment" ]
[ 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02476409
10:41:chronic_disease
Elevated jugular venous distension (JVD)
2
[ "Elevated", "jugular", "venous", "distension", "(", "JVD", ")" ]
[ 0, 2, 2, 2, 2, 0, 0 ]
NCT00107289
1:5:treatment,21:24:treatment,50:59:treatment
MIBG-avid malignant CCT and evaluable disease on MIBG scan at time of enrollment on protocol
2
[ "MIBG-avid", "malignant", "CCT", "and", "evaluable", "disease", "on", "MIBG", "scan", "at", "time", "of", "enrollment", "on", "protocol" ]
[ 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03175978
14:17:cancer,18:22:cancer,62:78:treatment,71:78:treatment
Diagnosis of MDS/CMML that is refractory to or intolerant to standard therapy and is no longer likely to respond to such therapy (at least one line of therapy)
2
[ "Diagnosis", "of", "MDS/CMML", "that", "is", "refractory", "to", "or", "intolerant", "to", "standard", "therapy", "and", "is", "no", "longer", "likely", "to", "respond", "to", "such", "therapy", "(", "at", "least", "one", "line", "of", "therapy", ")" ]
[ 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02978443
38:88:treatment
Patients must be eligible to receive nivolumab in combination with ipilimumab treatment per institutional guidelines
2
[ "Patients", "must", "be", "eligible", "to", "receive", "nivolumab", "in", "combination", "with", "ipilimumab", "treatment", "per", "institutional", "guidelines" ]
[ 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 1, 0, 0, 0 ]
NCT01895777
17:25:treatment
requirement for dialysis
2
[ "requirement", "for", "dialysis" ]
[ 0, 0, 1 ]
NCT02467478
1:52:treatment
Treatment with cytochrome p450 (CYP 3A4) inhibitors
2
[ "Treatment", "with", "cytochrome", "p450", "(", "CYP", "3A4", ")", "inhibitors" ]
[ 1, 1, 1, 1, 1, 1, 1, 0, 0 ]
NCT02463305
1:32:treatment
Prior surgical bowel resections
2
[ "Prior", "surgical", "bowel", "resections" ]
[ 1, 1, 1, 1 ]
NCT02495415
46:73:treatment,
Growth factor(s): Must not have received any hematopoetic growth factors within 7 days of study entry
2
[ "Growth", "factor", "(", "s", ")", ":", "Must", "not", "have", "received", "any", "hematopoetic", "growth", "factors", "within", "7", "days", "of", "study", "entry" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT03056287
1:17:chronic_disease
Severe arthritis or other problems that limit passive range of motion
2
[ "Severe", "arthritis", "or", "other", "problems", "that", "limit", "passive", "range", "of", "motion" ]
[ 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT00871260
1:24:chronic_disease
Hemodynamic instability
2
[ "Hemodynamic", "instability" ]
[ 2, 2 ]
NCT02179853
11:26:treatment,
Use of an IL-1 antagonist within the 3 months prior to enrollment
2
[ "Use", "of", "an", "IL-1", "antagonist", "within", "the", "3", "months", "prior", "to", "enrollment" ]
[ 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02417701
38:60:treatment
Patients who are receiving any other investigational agents
2
[ "Patients", "who", "are", "receiving", "any", "other", "investigational", "agents" ]
[ 0, 0, 0, 0, 0, 0, 1, 1 ]